Euler, M. V., Liljebris, C., Brisander, M., Andersson, P., Lennernäs, H., Darpö, B., Stenke, L. (2025). XS003, an amorphous re-formulation of nilotinib, demonstrates improved dose linearity and minimal food effect, reducing the risk of QT-prolongation at fed conditions. Blood. https://doi.org/10.1182/blood-2025-5547